Biostar Pharmaceuticals (BSPM +5%) rallies today ahead of its Q3 results due out Monday just...

This news story has 1 comment:

Register or Login to rate comments »

Alberto Abaterusso Comments (30)
 
With curiosity I am looking forward to Biostar Pharmaceuticals' Q3 (2012) results, but I do not expect to find a big surprise. As I mentioned in my recent instablog (http://bit.ly/UOooVi), Biostar is not so liquid as it seems at first sight. And it was also the major concern among investors that emerged from the last Conduct Conference Call of August 15th, 2012 (http://bit.ly/TS03JF). Let's see if and how BSPM's DSO has improved. To me you can announce to have sold more, but I also like to see that sales actually have been made and then that there is money in cash.
18 Nov 2012, 02:56 PM Reply Like